New England Capital Financial Advisors LLC Biogen Inc. Transaction History
New England Capital Financial Advisors LLC
- $177 Billion
- Q1 2024
A detailed history of New England Capital Financial Advisors LLC transactions in Biogen Inc. stock. As of the latest transaction made, New England Capital Financial Advisors LLC holds 113 shares of BIIB stock, worth $25,380. This represents 0.01% of its overall portfolio holdings.
Number of Shares
113
Previous 113
-0.0%
Holding current value
$25,380
Previous $29.2 Million
16.67%
% of portfolio
0.01%
Previous 0.02%
Shares
1 transactions
Others Institutions Holding BIIB
# of Institutions
1,047Shares Held
126MCall Options Held
1.37MPut Options Held
1.35M-
Vanguard Group Inc Valley Forge, PA16.6MShares$3.72 Billion0.07% of portfolio
-
Primecap Management CO Pasadena, CA16.2MShares$3.64 Billion2.65% of portfolio
-
Black Rock Inc. New York, NY14.1MShares$3.18 Billion0.07% of portfolio
-
State Street Corp Boston, MA6.75MShares$1.52 Billion0.07% of portfolio
-
T. Rowe Price Investment Management, Inc. Baltimore, MD5.17MShares$1.16 Billion0.68% of portfolio
About BIOGEN INC.
- Ticker BIIB
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 144,000,992
- Market Cap $32.3B
- Description
- Biogen Inc. discovers, develops, manufactures, and delivers therapies for treating neurological and neurodegenerative diseases. The company offers TECFIDERA, VUMERITY, AVONEX, PLEGRIDY, TYSABRI, and FAMPYRA for multiple sclerosis (MS); SPINRAZA for spinal muscular atrophy; and FUMADERM to treat plaque psoriasis. It also provides BENEPALI, an eta...